Elisa Tardelli

Prato, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

Familial Alzheimer's disease associated with heterozygous NPC1 mutation.

Familial Alzheimer's disease associated with heterozygous NPC1 mutation.

Journal: Journal of medical genetics
Published: February 14, 2023

Rethinking Tako-tsubo Cardiomyopathy: The Contribution of Myocardial Pathology and Molecular Imaging.

Rethinking Tako-tsubo Cardiomyopathy: The Contribution of Myocardial Pathology and Molecular Imaging.

Journal: Current radiopharmaceuticals
Published: September 01, 2022

[18F]-FDG-PET/CT Correlates With the Response of Radiorefractory Thyroid Cancer to Lenvatinib and Patient Survival.

[18F]-FDG-PET/CT Correlates With the Response of Radiorefractory Thyroid Cancer to Lenvatinib and Patient Survival.

Journal: The Journal of clinical endocrinology and metabolism
Published: February 07, 2021

Peptide receptor radionuclide therapy in patients with metastatic progressive pheochromocytoma and paraganglioma: long-term toxicity, efficacy and prognostic biomarker data of phase II clinical trials.

Peptide receptor radionuclide therapy in patients with metastatic progressive pheochromocytoma and paraganglioma: long-term toxicity, efficacy and prognostic biomarker data of phase II clinical trials.

Journal: ESMO open
Published: January 15, 2021

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy (PRRT): 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods.

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy (PRRT): 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods.

Journal: Journal of visualized experiments : JoVE
Published: May 12, 2020

Dosimetry and safety of 177Lu PSMA-617 along with polyglutamate parotid gland protector: preliminary results in metastatic castration-resistant prostate cancer patients.

Dosimetry and safety of 177Lu PSMA-617 along with polyglutamate parotid gland protector: preliminary results in metastatic castration-resistant prostate cancer patients.

Journal: European journal of nuclear medicine and molecular imaging
Published: December 23, 2019

Dosimetry of 177Lu-PSMA-617 after Mannitol Infusion and Glutamate Tablet Administration: Preliminary Results of EUDRACT/RSO 2016-002732-32 IRST Protocol.

Dosimetry of 177Lu-PSMA-617 after Mannitol Infusion and Glutamate Tablet Administration: Preliminary Results of EUDRACT/RSO 2016-002732-32 IRST Protocol.

Journal: Molecules (Basel, Switzerland)
Published: January 10, 2019

Clinical Impact of Radioguided Localization in the Treatment of Solitary Pulmonary Nodule: A 20-Year Retrospective Analysis.

Clinical Impact of Radioguided Localization in the Treatment of Solitary Pulmonary Nodule: A 20-Year Retrospective Analysis.

Journal: Clinical nuclear medicine
Published: February 13, 2018

Radioguided Occult Lesion Localization: Technical Procedures and Clinical Applications.

Radioguided Occult Lesion Localization: Technical Procedures and Clinical Applications.

Journal: Clinical nuclear medicine
Published: October 17, 2017

Sentinel Lymph Node Biopsy in Cutaneous Melanoma: Standard and New Technical Procedures and Clinical Advances. A Systematic Review of the Literature.

Sentinel Lymph Node Biopsy in Cutaneous Melanoma: Standard and New Technical Procedures and Clinical Advances. A Systematic Review of the Literature.

Journal: Clinical nuclear medicine
Published: October 18, 2016

Sentinel lymph node biopsy in breast cancer: a technical and clinical appraisal.

Sentinel lymph node biopsy in breast cancer: a technical and clinical appraisal.

Journal: Nuclear medicine communications
Published: February 18, 2016

Sentinel Lymph Node Biopsy in Breast Cancer: Indications, Contraindications, and Controversies.

Sentinel Lymph Node Biopsy in Breast Cancer: Indications, Contraindications, and Controversies.

Journal: Clinical nuclear medicine
Published: October 09, 2015
Showing 1-12 of 13

Last Updated: 09/26/2026